UNSPSC 51182438: Teriparatide acetate

This classification denotes a recombinant parathyroid hormone with the molecular formula C181H291N55O51S2.C2H4O2.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9959P4V12N. European Medicines Agency schedules teriparatide acetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04726MIG. The term teriparatide acetate is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule teriparatide acetate under HS 29371900 and SITC 54154.

As of Q4 2014, TERIPARATIDE ACETATE remains US FDA's Preferred Term for this commodity. Teriparatide acetate bears US NLM identifiers UMLS ID C1170286 and NCI Concept Code C66588. SMILES: CC(=O)O.O.

UNSPSC 51182438 Teriparatide acetate is a Commodity code covering a synthetic hormone injectable medication used to treat osteoporosis and related bone disorders in state and local procurement. State and local governments purchase teriparatide acetate primarily through public health departments, correctional facilities, veterans' services agencies, and integrated healthcare systems operated by counties and municipalities. The medication is procured as part of formulary management and pharmaceutical supply contracts for inpatient and outpatient clinical settings where patients with qualifying bone density conditions receive treatment.

The source provided contains no recent state and local contract opportunities tagged to this code. Without posted RFP, RFQ, IFB, or ITB records, geographic spread and representative solicitation activity cannot be characterized from current procurement signals.